+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Personalized Medicine Software Market - Global Forecast 2026-2032- Product Image
Personalized Medicine Software Market - Global Forecast 2026-2032- Product Image
Sale

Personalized Medicine Software Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6090202
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Personalized Medicine Software Market is projected to reach USD 2.78 Billion in 2026. It is expected to continue growing at a CAGR of 11.28%, reaching USD 5.31 Billion by 2032.

Personalized Medicine Software: Executive Overview

Personalized medicine software supports the collection, integration, interpretation, and application of patient-specific information in clinical and research settings. Its relevance is increasing as healthcare systems connect genomic, molecular, imaging, laboratory, clinical, and real-world data to guide more individualized decisions. The market is shaped by interoperability, evidence quality, workflow integration, privacy, cybersecurity, and the ability to translate complex data into usable clinical insights.

Interoperability and Evidence Are Reshaping Adoption

The landscape is shifting from isolated analytical tools toward connected platforms that fit existing clinical and research workflows. Open standards, application programming interfaces, cloud infrastructure, federated data approaches, and stronger data-governance practices are becoming important enablers. Adoption also depends on demonstrating clinical utility, reducing implementation friction, supporting multidisciplinary teams, and meeting evolving requirements for software validation, algorithm transparency, patient consent, and responsible data stewardship.

Artificial Intelligence Expands Analytical Reach and Accountability

Artificial intelligence can accelerate variant interpretation, identify patterns across multimodal datasets, support risk stratification, and help prioritize therapeutic or diagnostic options. Its cumulative impact depends on representative training data, external validation, explainability, monitoring for performance drift, and clear human oversight. Leaders should treat AI as a governed clinical capability rather than a standalone feature, with controls covering bias assessment, cybersecurity, documentation, auditability, and safe escalation when model outputs are uncertain.

Regional Insights: Different Infrastructure, Policy, and Access Conditions

North America benefits from advanced clinical research capacity, established precision-health programs, and comparatively mature digital infrastructure, while regulatory and reimbursement expectations remain central adoption considerations. Europe emphasizes cross-border data governance, interoperability, and privacy, with the European Union providing an important policy context. Asia-Pacific combines strong technology capabilities and large, diverse populations with uneven healthcare access and data standardization. Latin America is characterized by growing interest in genomic and digital health applications alongside infrastructure and affordability constraints. The Middle East is investing in modern healthcare systems and data capabilities, while Africa presents substantial opportunities for leapfrog deployment but requires attention to connectivity, workforce capacity, local validation, and equitable access.

Group Insights: Alliances Influence Standards and Implementation

ASEAN countries face varied levels of digital maturity, making interoperable architectures and regional capacity building particularly relevant. BRICS members bring substantial population scale, scientific capability, and diverse regulatory environments, but cross-border data practices and implementation models differ. The European Union places strong emphasis on privacy, trustworthy data use, and harmonized digital-health governance. G7 economies generally combine advanced research ecosystems with demanding expectations for clinical evidence, security, and responsible AI. GCC countries are strengthening coordinated health infrastructure and centralized data capabilities. NATO members may benefit from resilient digital infrastructure and security cooperation, although health-software deployment remains governed by national and regional healthcare rules.

Country Insights: National Priorities Shape Software Use

Australia is focused on digitally enabled care and research integration across a geographically dispersed system. Brazil and Mexico are balancing innovation with unequal access, fragmented infrastructure, and data-governance requirements. Canada emphasizes privacy, public-system interoperability, and evidence-based implementation. China is advancing data-intensive healthcare and domestic technology capabilities within a distinctive regulatory environment. France, Germany, Italy, Spain, and the United Kingdom are addressing interoperability, clinical validation, privacy, and public-sector integration through national and regional initiatives. India is combining expanding digital infrastructure with major diversity in healthcare access and data quality. Japan and South Korea bring strong technology and clinical capabilities, while Russia’s development context includes distinct regulatory, infrastructure, and data-access considerations. The United States remains a major environment for precision-health research, clinical innovation, and software validation, with reimbursement, regulatory compliance, and interoperability influencing adoption.

Action Priorities for Leaders: Govern Data, Validate AI, Integrate Workflows

Industry leaders should begin with clearly defined clinical or research use cases and measurable outcomes rather than technology-first deployments. They should build interoperable data foundations, establish consent and access controls, and create governance structures that include clinicians, data scientists, patients, compliance specialists, and cybersecurity teams. AI capabilities should be validated on relevant populations, monitored after deployment, and presented with understandable uncertainty indicators. Partnerships with healthcare providers, laboratories, researchers, and public institutions can strengthen evidence and implementation. Finally, organizations should design for local infrastructure, workforce skills, affordability, and regulatory expectations so that personalization improves care without widening disparities.

Research Methodology: Evidence-Led Market Assessment

This executive summary uses a structured review of the personalized medicine software landscape, focusing on technology functions, clinical and research workflows, enabling infrastructure, regulation, data governance, artificial intelligence, and implementation conditions. Analysis is organized across the required regions, country groups, and countries to identify recurring adoption drivers and constraints. Conclusions are limited to qualitative, data-backed industry insights and deliberately exclude market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims.

Conclusion: Responsible Integration Will Define Durable Progress

Personalized medicine software is becoming an important layer connecting complex biomedical data with individualized healthcare decisions. Sustainable progress will depend less on analytical sophistication alone than on interoperability, evidence, trustworthy AI, privacy protection, cybersecurity, and practical workflow integration. Organizations that combine rigorous validation with inclusive implementation and regionally appropriate governance will be better positioned to translate personalization into safer, more effective, and more equitable care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Personalized Medicine Software Market, by Type
7.1. Introduction
7.2. EHR Integration
7.3. Genomic Data Analysis
7.4. Patient Satisfaction & Risk Assessment
7.5. Predictive Analysis
7.6. Treatment Recommendation Engine
8. Personalized Medicine Software Market, by Application
8.1. Introduction
8.2. Cardiology
8.3. Neurology
8.4. Oncology
9. Personalized Medicine Software Market, by Deployment Mode
9.1. Introduction
9.2. On-cloud
9.3. On-premises
10. Personalized Medicine Software Market, by End User
10.1. Introduction
10.2. Healthcare Providers
10.2.1. Clinics
10.2.2. Hospitals
10.3. Research Institutes
10.3.1. Academic Institutes
10.3.2. Independent Labs
11. Personalized Medicine Software Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Personalized Medicine Software Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Personalized Medicine Software Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 23andMe, Inc.
15.2. 3D Systems, Inc.
15.3. Caris Life Sciences, Inc.
15.4. Epic Systems Corporation
15.5. Flatiron Health, Inc.
15.6. Foundation Medicine, Inc.
15.7. Genelex Corporation
15.8. Genomind, Inc.
15.9. Health Fidelity, Inc.
15.10. IBM Corporation
15.11. Illumina, Inc.
15.12. Innowise
15.13. Invitae Corporation
15.14. NantHealth, Inc.
15.15. OSP Labs
15.16. Personal Genome Diagnostics, Inc.
15.17. Roche Holding AG
15.18. Strand Life Sciences Pvt. Ltd.
15.19. Syapse, Inc.
15.20. Tempus AI, Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Personalized Medicine Software Market, Years Considered for the Study
FIGURE 2. Global Personalized Medicine Software Market, Research Design
FIGURE 3. Global Personalized Medicine Software Market, Research Framework
FIGURE 4. Global Personalized Medicine Software Market, Data Triangulation
FIGURE 5. Global Personalized Medicine Software Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Personalized Medicine Software Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Personalized Medicine Software Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Personalized Medicine Software Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Personalized Medicine Software Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Personalized Medicine Software Market Size, by Deployment Mode, 2025 vs 2032 (%)
FIGURE 11. Global Personalized Medicine Software Market Size, by Deployment Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Personalized Medicine Software Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Personalized Medicine Software Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Personalized Medicine Software Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Personalized Medicine Software Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Personalized Medicine Software Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Personalized Medicine Software Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Personalized Medicine Software Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Personalized Medicine Software Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Personalized Medicine Software Market Segmentation & Coverage
TABLE 2. Global Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 3. Global Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global EHR Integration Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global EHR Integration Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global EHR Integration Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Genomic Data Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Genomic Data Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Genomic Data Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Patient Satisfaction & Risk Assessment Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Patient Satisfaction & Risk Assessment Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Patient Satisfaction & Risk Assessment Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Predictive Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Predictive Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Predictive Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Treatment Recommendation Engine Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Treatment Recommendation Engine Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Treatment Recommendation Engine Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 20. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 30. Global On-cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global On-cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global On-cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global On-premises Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global On-premises Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global On-premises Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 37. Global Healthcare Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Healthcare Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Healthcare Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Independent Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Independent Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Independent Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Personalized Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Personalized Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 63. North America Personalized Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. North America Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 65. North America Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 66. North America Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 67. North America Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. North America Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 69. North America Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 70. Latin America Personalized Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Latin America Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 72. Latin America Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. Latin America Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 74. Latin America Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Latin America Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 76. Latin America Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 77. Europe Personalized Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Europe Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 79. Europe Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Europe Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 81. Europe Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Europe Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 83. Europe Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 84. Middle East Personalized Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Middle East Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 86. Middle East Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 87. Middle East Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 88. Middle East Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Middle East Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 90. Middle East Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 91. Africa Personalized Medicine Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Africa Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 93. Africa Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Africa Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 95. Africa Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Africa Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 97. Africa Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 98. Global Personalized Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. ASEAN Personalized Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. ASEAN Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 101. ASEAN Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. ASEAN Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 103. ASEAN Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. ASEAN Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 105. ASEAN Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 106. GCC Personalized Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. GCC Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 108. GCC Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. GCC Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 110. GCC Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. GCC Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 112. GCC Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 113. European Union Personalized Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. European Union Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 115. European Union Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. European Union Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 117. European Union Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. European Union Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 119. European Union Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 120. BRICS Personalized Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. BRICS Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 122. BRICS Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 123. BRICS Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 124. BRICS Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. BRICS Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 126. BRICS Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 127. G7 Personalized Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. G7 Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 129. G7 Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. G7 Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 131. G7 Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. G7 Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 133. G7 Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 134. NATO Personalized Medicine Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. NATO Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 136. NATO Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. NATO Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 138. NATO Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. NATO Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 140. NATO Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 141. Global Personalized Medicine Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. United States Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 143. United States Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 144. United States Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. United States Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 146. United States Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. United States Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 148. United States Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 149. Canada Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 150. Canada Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 151. Canada Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. Canada Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 153. Canada Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Canada Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 155. Canada Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 156. Mexico Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 157. Mexico Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 158. Mexico Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. Mexico Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 160. Mexico Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Mexico Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 162. Mexico Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 163. Brazil Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 164. Brazil Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 165. Brazil Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. Brazil Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 167. Brazil Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. Brazil Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 169. Brazil Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 170. United Kingdom Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 171. United Kingdom Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 172. United Kingdom Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. United Kingdom Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 174. United Kingdom Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. United Kingdom Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 176. United Kingdom Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 177. Germany Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 178. Germany Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 179. Germany Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. Germany Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 181. Germany Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Germany Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 183. Germany Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 184. France Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 185. France Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 186. France Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. France Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 188. France Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. France Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 190. France Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 191. Russia Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 192. Russia Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 193. Russia Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. Russia Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 195. Russia Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Russia Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 197. Russia Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 198. Italy Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 199. Italy Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 200. Italy Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Italy Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 202. Italy Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Italy Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 204. Italy Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 205. Spain Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 206. Spain Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 207. Spain Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Spain Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 209. Spain Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Spain Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 211. Spain Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 212. China Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 213. China Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 214. China Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. China Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 216. China Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. China Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 218. China Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 219. India Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 220. India Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 221. India Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. India Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 223. India Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. India Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 225. India Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 226. Japan Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 227. Japan Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 228. Japan Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. Japan Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 230. Japan Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Japan Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 232. Japan Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 233. Australia Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 234. Australia Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 235. Australia Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. Australia Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 237. Australia Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. Australia Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 239. Australia Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 240. South Korea Personalized Medicine Software Market Size, 2017-2032 (USD Million)
TABLE 241. South Korea Personalized Medicine Software Market Size, by Type, 2017-2032 (USD Million)
TABLE 242. South Korea Personalized Medicine Software Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. South Korea Personalized Medicine Software Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 244. South Korea Personalized Medicine Software Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. South Korea Personalized Medicine Software Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 246. South Korea Personalized Medicine Software Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 247. Global Personalized Medicine Software Market Share, by Key Player, 2025
TABLE 248. Global Personalized Medicine Software Market, Key Experts

Companies Mentioned

  • 23andMe, Inc.
  • 3D Systems, Inc.
  • Caris Life Sciences, Inc.
  • Epic Systems Corporation
  • Flatiron Health, Inc.
  • Foundation Medicine, Inc.
  • Genelex Corporation
  • Genomind, Inc.
  • Health Fidelity, Inc.
  • IBM Corporation
  • Illumina, Inc.
  • Innowise
  • Invitae Corporation
  • NantHealth, Inc.
  • OSP Labs
  • Personal Genome Diagnostics, Inc.
  • Roche Holding AG
  • Strand Life Sciences Pvt. Ltd.
  • Syapse, Inc.
  • Tempus AI, Inc.

Related Topics

Related Reports

Personalized Medicine Market - Global Forecast 2026-2032 - Product Image

Personalized Medicine Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Personalized Medicine Bioinformatics Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology (Gene Sequencing, Pharmacogenomics, Microarray Technology, AI-driven Analytics Platforms, Other Technologies), Application, End User - Product Image

Personalized Medicine Bioinformatics Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology (Gene Sequencing, Pharmacogenomics, Microarray Technology, AI-driven Analytics Platforms, Other Technologies), Application, End User

  • Report
  • 160 Pages
  • Global
From
Molecular Cytogenetics Market by Product (Kits, Reagents, Probes, Instrument, Software, Services), Technique (FISH, CISH, Comparative Genomic Hybridization [Array-based, Standard]), Application (Cancer, Personalized Medicine) - Global Forecast to 2030 - Product Image

Molecular Cytogenetics Market by Product (Kits, Reagents, Probes, Instrument, Software, Services), Technique (FISH, CISH, Comparative Genomic Hybridization [Array-based, Standard]), Application (Cancer, Personalized Medicine) - Global Forecast to 2030

  • Report
  • 377 Pages
  • Global
From
Personalized Medicine Bioinformatics Market Report 2026 - Product Image

Personalized Medicine Bioinformatics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Hyper-Personalized Medicine Market Report 2026 - Product Image

Hyper-Personalized Medicine Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.